We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.11B
AUM Growth
+$673M
Cap. Flow
-$283M
Cap. Flow %
-6.89%
Top 10 Hldgs %
37.55%
Holding
125
New
30
Increased
16
Reduced
24
Closed
24

Top Buys

Rank Stock Value
1
AFIB
Acutus Medical Inc
AFIB
+$132M
2
CALC icon
CalciMedica
CALC
+$78.7M
3
NKTX icon
Nkarta
NKTX
+$71.3M
4
CNC icon
Centene
CNC
+$58.5M
5
OSH
Oak Street Health, Inc.
OSH
+$42.6M

Top Sells

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$123M
2
HOLX
Hologic
HOLX
+$62.2M
3
MCK icon
McKesson
MCK
+$42.7M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$31.2M
5
PCRX icon
Pacira BioSciences
PCRX
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 62.18%
2 Financials 1.23%
3 Industrials 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIEN
76
DELISTED
Sientra, Inc.
SIEN
$7.89M 0.19%
232,022
-184,258
-44% -$6.98M
STIM icon
77
Neuronetics
STIM
$130M
$7.66M 0.19%
1,575,000
-118,317
-7% -$449K
OXFD
78
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.35M 0.18%
628,139
-216,861
-26% -$2.88M
OM icon
79
Outset Medical
OM
$87.5M
$6.25M 0.15%
+8,333
New +$6.84M
PANA.U
80
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$6M 0.15%
+500,000
New +$5.75M
AERI
81
DELISTED
Aerie Pharmaceuticals
AERI
$5.82M 0.14%
494,216
– –
TSHA icon
82
Taysha Gene Therapies
TSHA
$1.57B
$5.6M 0.14%
+250,000
New +$5.88M
ARYBU
83
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$5.5M 0.13%
500,000
– –
CABA icon
84
Cabaletta Bio
CABA
$445M
$5.03M 0.12%
464,252
– –
GNMK
85
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.5M 0.06%
+175,806
New +$2.69M
VKTX icon
86
Viking Therapeutics
VKTX
$3.93B
$2.03M 0.05%
+348,441
New +$2.4M
MNK
87
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.92M 0.05%
1,970,687
– –
PMVP icon
88
PMV Pharmaceuticals
PMVP
$58.7M
$1.77M 0.04%
+50,000
New +$1.84M
CERS icon
89
Cerus
CERS
$585M
$533K 0.01%
85,143
-2,119,557
-96% -$14.1M
ALIM
90
DELISTED
Alimera Sciences
ALIM
$332K 0.01%
+68,413
New +$402K
NEOS
91
DELISTED
Neos Therapeutics, Inc
NEOS
$170K ﹤0.01%
320,993
– –
WINT
92
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
APLT
93
DELISTED
Applied Therapeutics
APLT
– –
-278,359
Closed -$10.1M
DBVT
94
DBV Technologies
DBVT
$799M
– –
-515,416
Closed -$22.6M
FOLD
95
DELISTED
Amicus Therapeutics
FOLD
– –
-1,416,000
Closed -$21.4M
KROS icon
96
Keros Therapeutics
KROS
$199M
– –
-300,000
Closed -$11.3M
MCK icon
97
McKesson
MCK
$104B
– –
-278,085
Closed -$42.7M
ORIC icon
98
Oric Pharmaceuticals
ORIC
$1.23B
– –
-300,000
Closed -$10.1M
RCKT icon
99
Rocket Pharmaceuticals
RCKT
$343M
– –
-53,043
Closed -$1.11M
SDGR icon
100
Schrodinger
SDGR
$1.14B
– –
-1,346,167
Closed -$123M
1 2 3
4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2020 Portfolio in Review

As of Q3 2020, Deerfield Management held 125 positions worth $4.11B, up 20% from $3.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Deerfield Management withdrew a net $283M in Q3 2020, closing 24 positions and reducing 24 holdings. Its most notable exit was Schrodinger, an estimated $123M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 66% a quarter earlier, followed by Financials and Industrials.

Against the trend, Deerfield Management opened a new position in Acutus Medical Inc worth $129M.

  • Deerfield Management's largest Q3 2020 buy was Acutus Medical Inc: 4,341,799 shares worth $129M.
  • Deerfield Management added most to Centene in Q3 2020, an estimated $58.5M increase.
  • Deerfield Management's biggest Q3 2020 reduction was Hologic, cutting an estimated $62.2M.
  • Deerfield Management fully exited Schrodinger in Q3 2020, selling an estimated $123M.
  • Deerfield Management's ten largest holdings make up 38% of its $4.11B portfolio in Q3 2020.
  • Deerfield Management opened 30 new positions and closed 24 in Q3 2020.
  • Deerfield Management's portfolio value rose 20% quarter-over-quarter to $4.11B.

Based on Deerfield Management's 13F filing for Q3 2020, filed 16 Nov 2020.